↓ Skip to main content

Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis

Overview of attention for article published in Radiation Oncology, January 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis
Published in
Radiation Oncology, January 2015
DOI 10.1186/s13014-014-0320-5
Pubmed ID
Authors

Hong Yoon, Jihye Cha, Ki Keum, Ha Lee, Eun Nam, Sang Kim, Sunghoon Kim, Young Kim, Gwi Kim, Yong Kim

Abstract

PurposeTo review the clinical outcomes of extended-field radiation therapy (EFRT) and to analyze prognostic factors significant for survival in patients receiving EFRT for uterine cervical carcinoma with para-aortic node (PAN) metastasis.Patients and methodsWe retrospectively reviewed 90 patients with stage IB-IVA cervical cancer and PAN metastasis between 1987 and 2012. Median age was 50 (range, 24¿77). Patients received median 70.2 Gy (range, 56¿93) to point A and median 50.4 Gy (range, 45¿60.4) to PAN over median 69 elapsed days (range, 43¿182). Forty-six patients (51.1%) received concurrent chemotherapy. Survival was calculated using the Kaplan¿Meier method. We analyzed prognostic factors for overall actuarial survival (OS) and progression-free survival (PFS) using a Cox regression method.ResultsThe median follow-up period for surviving patients was 55 months (range, 3¿252). Seventy patients (77.8%) had complete remission. Forty-six patients experienced treatment failure as follows: 11 patients (12.2%) as local recurrence, 19 (21%) as regional recurrence and 33 (36.7%) as distant metastasis. The 5-yr OS and PFS were 62.6% and 43.9%, respectively. Treatment response was the only statistically independent prognostic factors for OS (p= 0.04) and PFS (p< 0.001) on multivariate analysis. Grade 3 or 4 hematologic gastrointestinal and urogenital toxicities were observed in about 10% of patients.ConclusionsOur institutional experiences showed that EFRT was an effective treatment for cervical cancer patients with PAN metastasis. The addition of chemotherapy to EFRT seems to have uncertain survival benefit with higher hematologic toxicity.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 3 18%
Researcher 3 18%
Student > Bachelor 2 12%
Student > Ph. D. Student 1 6%
Student > Master 1 6%
Other 2 12%
Unknown 5 29%
Readers by discipline Count As %
Medicine and Dentistry 9 53%
Nursing and Health Professions 2 12%
Psychology 1 6%
Unknown 5 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2016.
All research outputs
#11,056,394
of 12,437,730 outputs
Outputs from Radiation Oncology
#1,145
of 1,302 outputs
Outputs of similar age
#228,665
of 280,115 outputs
Outputs of similar age from Radiation Oncology
#173
of 184 outputs
Altmetric has tracked 12,437,730 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,302 research outputs from this source. They receive a mean Attention Score of 2.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,115 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 184 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.